105
Participants
Start Date
November 27, 2017
Primary Completion Date
August 29, 2018
Study Completion Date
November 21, 2018
Narlaprevir
100 mg, oval shaped, concave, yellow film-coated, tablets taken as 200 mg per os daily
Ritonavir
100 mg, tablets, taken as 100 mg per os daily
Daclatasvir
60 mg, tablets, taken as 60 mg per os daily
FBIS CSRI of Epidemiology of Federal Service on Customers, Moscow
SBEI HPE Moscow State Medical and Dental University n.a. A.I. Evdokimov of Ministry of Health of Russia, Moscow
"SBHI of Moscow City Clinical Hospital #24", Moscow
St. Petersburg SBHI Center of Prevention and Fight against AIDS and Infection Diseases, Saint Petersburg